How to inject tirzepatide: a step-by-step guide

Each Mounjaro KwikPen contains four weekly doses, delivered as a once-weekly subcutaneous injection into the fat layer just beneath the skin.
Three licensed sites: abdomen (at least 5 cm from the navel), front or outer thigh, and upper arm — rotate between them each week to protect the skin.
Never inject into a muscle or vein; subcutaneous tissue only. Avoid broken, bruised, tender, or scarred skin.
Used needles must be disposed of safely in an approved sharps container immediately after each injection, never recapped or shared.

To inject tirzepatide, choose a site on your abdomen, thigh, or upper arm, clean the skin with an alcohol swab, press the Mounjaro KwikPen firmly against it, and press the button until the injection is complete — the whole process takes under a minute. Tirzepatide (sold in the UK as Mounjaro) is a prescription-only medicine; a GPhC-registered prescriber will assess your suitability before any treatment begins, and your Patient Information Leaflet is the definitive reference for your specific pen and dose.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Everything that happens from pen to plunger, and why each step matters

What do you actually need before you inject tirzepatide?

Gather everything first, because rushing mid-injection is where mistakes creep in. You'll need your Mounjaro KwikPen (check the expiry date and that the liquid is clear and colourless, a cloudy or discoloured solution should not be used), a fresh needle if your pen requires one, an alcohol swab, and a sharps disposal container within reach.

Take the pen out of the fridge about 30 minutes before you plan to inject. Cold medicine going in straight from 2–8°C storage is perfectly safe, but many people find it more comfortable at room temperature. Wash your hands thoroughly first, soap and water, at least 20 seconds.

Check the dose window. The Mounjaro KwikPen is pre-set at the dose your prescriber has authorised; you don't adjust it yourself. If anything looks wrong (wrong dose window, damaged pen, missing needle cover) don't inject and contact your prescriber or our support team.

A note our prescribers hear from patients: the anticipation before the first injection is almost always worse than the injection itself. The needle is very fine and the depth is shallow. Most people are genuinely surprised by how little they notice it.

How do you inject tirzepatide correctly, step by step?

Clean your chosen site with an alcohol swab and let the skin dry completely, injecting through wet skin can cause a brief sting. Pinch a fold of skin gently with your free hand if your injection site has less subcutaneous fat (the thigh or upper arm, typically), though this isn't always needed at the abdomen.

Place the pen flat against the skin at roughly a 90-degree angle. Press it firmly so the skin contact is solid, then press and hold the injection button. You'll hear and feel a click as it starts. Keep the pen pressed against your skin until the dose counter returns to zero and a second click confirms delivery is complete, lifting the pen too early is the most common reason for an incomplete dose.

Release the button, then lift the pen away. A small amount of blood or clear fluid at the site is normal. Press gently with a clean piece of cotton or gauze if needed, but do not rub, rubbing can cause local irritation. For a detailed look at technique specific to the upper arm, our upper-arm injection guide walks through the extra considerations for that site.

The NHS tirzepatide medicines page also confirms the injection process and is worth bookmarking alongside your Patient Information Leaflet.

Where should you inject tirzepatide, and does the site affect how it works?

The three licensed sites are the abdomen, the front or outer thigh, and the upper arm. Rotating between them each week matters: repeatedly injecting into the same spot causes lipohypertrophy, a lumpy thickening of the fat tissue that slows absorption and can make the injection less predictable. Keep a simple mental or written log of where you injected last.

Absorption rates do vary slightly between sites, though not in a way that changes your overall treatment. For a fuller breakdown of how to choose and rotate sites, our injection-site guide covers each location with practical tips.

Timing matters too. Most people pick a consistent day of the week (the same day keeps the interval close to seven days) though you have some flexibility. Our guide on when to inject tirzepatide covers what to do if your day shifts, and when to contact your prescriber rather than self-adjust.

If you'd like a broader overview of how tirzepatide works as a treatment, the tirzepatide injection overview explains the mechanism and the licensed dose schedule in plain language.

What should you watch out for after injecting?

Mild redness, itching, or a small bump at the injection site are common and usually resolve within a day or two. Rotating sites, as above, is the best prevention. Nausea is the most frequently reported side effect in the weeks after starting or after a dose increase, it's typically mild to moderate and settles as your body adjusts, though timing your injection in the evening can help some people sleep through the worst of it.

Seek medical help promptly for severe or persistent stomach pain that radiates towards your back. In January 2026, the MHRA issued a Drug Safety Update highlighting acute pancreatitis as a known, infrequent but serious risk with GLP-1 medicines, this symptom pattern warrants urgent assessment, not a wait-and-see approach. You can report any suspected side effect directly via the MHRA's Yellow Card scheme.

Dispose of the used needle immediately in your sharps container. Never re-use or share needles. Store your remaining pens in the fridge; if you need to carry one while travelling, your Patient Information Leaflet states the maximum room-temperature storage window, always follow that guidance rather than a general estimate. Questions about your specific dose or any symptom should go to your prescriber or our aftercare team, available seven days a week. You can also read more about the Mounjaro injection process generally if you're weighing up how treatment fits into your routine.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions